J.P. Morgan’s life sciences outlook for 2021 [Sponsored] April 1, 2021 Auto Bot Acquisitions, BioPharma, biopharma nl, Diagnostics, Health IT, IPO, JP Morgan, News, sponsored content, Sponsored Post, venture capital 0 Peter Meath, J.P. Morgan Commercial Banking’s Co-Head of Healthcare and Life Sciences, applies lessons from 2020’s remarkable second half and shares insights on what to expect in 2021.